The Dow Chemical Company has released its 2017 Sustainability Report, detailing its progress against its 2025 Sustainability Goals and how Dow employees are helping drive value and deliver transformative and more sustainable ways to do business. Highlights from the report include: Generated $120 million in value for “Valuing Nature” projects Achieved or exceeded annual targets […]
Post Type Archives: News
Covestro launches worldwide digitalization program
With a comprehensive program, Covestro is driving digitalization forward in operations. The program will be rolled out globally in the coming years. Priority is being given to the areas of facility engineering, operations and manufacturing on a global scale. It is intended to make processes even more efficient. “We will foster the further digitalization of […]
ACC forecasts 3.4% growth for US chemicals production in 2018
Following a mixed year in 2017, the foundation is set for better performance by the U.S. chemical industry in 2018, according to the American Chemistry Council’s (ACC) Mid-Year 2018 Chemical Industry Situation and Outlook. Strong global growth prospects, rising exports, an upswing in manufacturing, balanced chemical inventories, healthy demand from end-use markets, and favorable shale […]
Syngenta launches Seedcare Institute on campus of Charles Sturt University
Syngenta has announced the launch of its Australian Seedcare Institute at the International Seed Federation conference in Brisbane, Australia. The Wagga Wagga Seedcare Institute will join Syngenta’s global network of 14 facilities, leveraging world-class expertise and technology. Seed treatment application can be a complex activity that dramatically impacts the performance of seeds in the field […]
Fera Science completes Europe’s most advanced flow-through mesocosm
Translational science and research organisation, Fera Science Ltd has announced that building work has completed on a new testing facility in Sand Hutton, near York in the UK. The E-Flows mesocosm is a ground breaking project developed in partnership by Fera, the Centre for Crop Health and Protection (CHAP) and supported by Innovate UK. It […]
Bayer closes Monsanto acquisition (at last!)
Bayer successfully completed the acquisition of Monsanto on Thursday 7th June 2018. Shares in the US company will no longer be traded on the New York Stock Exchange, with Bayer now the sole owner of Monsanto Company. Monsanto shareholders are being paid $128 per share. JP Morgan assisted Bayer with processing the purchase price payment […]
Emergent invests $50 million to expand fill/finish facility
Emergent Biosolutions has unveiled plans for the beginning of a $50 million expansion to the company’s Camden fill/finish facility located in Baltimore, MD. The multi-year expansion is expected to be completed in 2021, and will significantly increase the company’s contract development and manufacturing capacity, redundancy, and flexibility. This expansion is also anticipated to create up […]
Vetter launches Open Innovation Challenge
How can digital trends be used purposefully in regards to the application of injection systems? That is the key question being addressed by Vetter’s Open Innovation Challenge. This new campaign, created by the Contract Development and Manufacturing Organization (CDMO) was officially launched today at a workshop in Ravensburg. The purpose of the challenge is to […]
Abeona opens commercial gene & cell therapy manufacturing facility
Abeona Therapeutics, a Dallas, Texas-headquartered clinical-stage biopharmaceutical company, has opened a commercial GMP manufacturing facility for gene and cell therapies in Cleveland, Ohio called The Elisa Linton Center for Rare Disease Therapies. The GMP facility is designed to manufacture clinical and commercial-grade products over Abeona’s multiple clinical programs, including therapies to treat recessive dystrophic epidermolysis […]
FDA proposes process modernization to support new drug development
The US Food and Drug Administration (FDA) has proposed process changes and organizational restructuring to modernize the new drug regulatory program, with the goalof improving efficiency by at least 20%. “These changes are intended to free up resources so that our scientists and physicians have more time to focus on drug development, particularly for unmet […]